|
|
|
|
US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatment
CHARLOTTE, N.C., Feb.9 /PRNewswire/ -- US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research...
|
|
|
US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatm
ent CHARLOTTE, N.C., Feb.9 /PRNewswire/ -- US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research...
|
|
|
US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatment
CHARLOTTE, N.C., Feb.9 /PRNewswire/ -- US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research...
|
|
|
US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatment
CHARLOTTE, N.C., Feb.9 /PRNewswire/ -- US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research...
|
|
|
US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatment
CHARLOTTE, N.C., Feb.9 /PRNewswire/ -- US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research...
|
|
|
US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatment
CHARLOTTE, N.C., Feb.9 /PRNewswire/ -- US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research...
|
|
|
US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatment
CHARLOTTE, N.C., Feb.9 /PRNewswire/ -- US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research...
|
|
|
US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatment
CHARLOTTE, N.C., Feb.9 /PRNewswire/ -- US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research...
|
|
|
US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatment
CHARLOTTE, N.C., Feb.9 /PRNewswire/ -- US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research...
|
|
|
US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatment
CHARLOTTE, N.C., Feb.9 /PRNewswire/ -- US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research...
|
|
|
US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatment
CHARLOTTE, N.C., Feb.9 /PRNewswire/ -- US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research...
|
|
|
SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly
NEW YORK, Feb.9 /PRNewswire/ -- LIVESTRONG Quarterly is a new online, print and print-on-demand publication from LIVESTRONG. The magazine features profiles of survivors and supporters in the fight against cancer; resources and information about ...
|
|
|
US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatment
PR Newswire CHARLOTTE, N.C., Feb.9 CHARLOTTE, N.C., Feb. 9 /PRNewswire/ -- US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive...
|
|
|
PET/CT uncovers cancer underlying neurologic disorders
Cancer patients sometimes develop neurologic complications directly caused by their cancers.Sometimes, however, these disorders are due not to the growth of a cancer tumor but to cancer-fighting antibodies that mistakenly attack cells...
|
|
|
New Advances in Prostate Cancer Screening Prostate Saturation Biopsies
Prostate Cancer treatment specialist Dr.Gregory Echt is excited about a procedure called Prostate Saturation Biopsy which will provide much better information on whether a man has prostate cancer than the prostate specific...
|
|
|
J. Armand Bombardier Foundation supports prostate cancer research
MONTREAL, Feb.9 /CNW Telbec/ - Concerned with the health and well being of Canadians, the J. Armand Bombardier Foundation has donated $200 000 to the PROCURE Quebec Prostate Cancer Biobank, a tool to accelerate the pace of research on ...
|
|
|
J. Armand Bombardier Foundation supports prostate cancer research
MONTREAL, Feb.9, 2010 (Canada NewsWire via COMTEX) ----Concerned with the health and well being of Canadians, the J. Armand Bombardier Foundation has donated $200 000 to the PROCURE Quebec Prostate Cancer Biobank, a tool to accelerate the pace...
|
|
|
J. Armand Bombardier Foundation supports prostate cancer research...
Company: Bombardier Inc.(BDRAF) Concerned with the health and well being of Canadians, the J. Armand Bombardier Foundation has donated $200 000 to the PROCURE Quebec Prostate Cancer Biobank, a tool to accelerate the pace of research on ...
|
|
|
A V Foundation SPORE Clinical Trial Supplement Grant Awarded To The University of Pittsburgh Cancer Institute
CARY, N.C.-- The V Foundation for Cancer Research, one of the nations leading cancer research fundraising organizations, announced that a Supplement to the Lung Cancer Specialized Program of Research Excellence (SPORE) grant to support...
|
|
|
Research: Lower Detection of Prostate Cancer With PSA Screening in US Than in a European Randomized Trial
A new brief communication published online February 8 in the Journal of the National Cancer Institute says that fewer prostate cancers were detected by prostate-specific antigen (PSA) screening in the U.S.than in a European randomized...
|
|
|
Lower Detection Of Prostate Cancer With PSA Screening In US Than In European Randomized Trial
Fewer prostate cancers were detected by prostate-specific antigen (PSA) screening in the U.S.than in a European randomized trial because of lower screening sensitivity, according to a new brief communication published online February 8 in...
|
|
|
Women Against Prostate Cancer Support Group Launches Updated Website
Find resources, womens stories and more FOR IMMEDIATE RELEASE PR Log (Press Release) Feb 08, 2010 Women Against Prostate Cancer (WAPC), a prostate cancer education and advocacy organization geared toward women and families affected by ...
|
|
|
PSA screening for prostate cancer is less sensitive in USA than European trial
J Natl Cancer Inst 2010; Advance online publication MedWire News: A Dutch research team has shown that prostate-specific antigen (PSA) screening protocols in the USA are less effective at identifying prostate cancer than those used in...
|
|
|
Lower detection of prostate cancer with PSA screening in US than in a European randomized trial
Fewer prostate cancers were detected by prostate-specific antigen (PSA) screening in the U.S.than in a European randomized trial because of lower screening sensitivity, according to a new brief communication published online February 8 in...
|
|
|
Protein Discovery Changes Prostate Cancer Treatment
Prostate cancer, breast cancer and enlarged hearts could be getting a new approach to treatment because of a protein called RSK."When activated, RSK is involved in cell survival, cell proliferation and cell enlargement," according to Loyola...
|
